Prediction of six months' remission in 1004 patients with rheumatoid arthritis starting adalimumab as first biological treatment. Results of machine learning models in patients from the Danish DANBIO registry

Nikolin Prenga; Niels Steen Krogh; A Akkoc; Merete Lund Hetland; Bente Glintborg

Prediction of six months' remission in 1004 patients with rheumatoid arthritis starting adalimumab as first biological treatment. Results of machine learning models in patients from the Danish DANBIO registry

Nikolin Prenga, Niels Steen Krogh, A Akkoc, Merete Lund Hetland, Bente Glintborg

Department for Rheumatology and Spine Diseases

Original language	English
Publication date	2023
Publication status	Published - 2023
Event	Scandinavian Congress of Rheumatology SCR2023 - København, Denmark Duration: 23 Aug 2023 → 26 Aug 2023

Conference

Conference	Scandinavian Congress of Rheumatology SCR2023
Country/Territory	Denmark
City	København
Period	23/08/2023 → 26/08/2023

Cite this

Prenga, N., Krogh, N. S., Akkoc, A., Hetland, M. L., & Glintborg, B. (2023). Prediction of six months' remission in 1004 patients with rheumatoid arthritis starting adalimumab as first biological treatment. Results of machine learning models in patients from the Danish DANBIO registry. SCR 52(Supplement 131) (pp 21-23). Abstract from Scandinavian Congress of Rheumatology SCR2023, København, Denmark.

Prediction of six months' remission in 1004 patients with rheumatoid arthritis starting adalimumab as first biological treatment. Results of machine learning models in patients from the Danish DANBIO registry. / Prenga, Nikolin; Krogh, Niels Steen; Akkoc, A et al.
2023. SCR 52(Supplement 131) (pp 21-23) Abstract from Scandinavian Congress of Rheumatology SCR2023, København, Denmark.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Prenga, N, Krogh, NS, Akkoc, A, Hetland, ML & Glintborg, B 2023, 'Prediction of six months' remission in 1004 patients with rheumatoid arthritis starting adalimumab as first biological treatment. Results of machine learning models in patients from the Danish DANBIO registry', Scandinavian Congress of Rheumatology SCR2023, København, Denmark, 23/08/2023 - 26/08/2023 pp. SCR 52(Supplement 131) (pp 21-23).

@conference{c438d338d7544cd3bba01707f4f6a0d8,

title = "Prediction of six months' remission in 1004 patients with rheumatoid arthritis starting adalimumab as first biological treatment. Results of machine learning models in patients from the Danish DANBIO registry",

author = "Nikolin Prenga and Krogh, \{Niels Steen\} and A Akkoc and Hetland, \{Merete Lund\} and Bente Glintborg",

note = "COPECARE; Scandinavian Congress of Rheumatology SCR2023 ; Conference date: 23-08-2023 Through 26-08-2023",

year = "2023",

language = "English",

pages = "SCR 52(Supplement 131) (pp 21--23)",

}

TY - ABST

T1 - Prediction of six months' remission in 1004 patients with rheumatoid arthritis starting adalimumab as first biological treatment. Results of machine learning models in patients from the Danish DANBIO registry

AU - Prenga, Nikolin

AU - Krogh, Niels Steen

AU - Akkoc, A

AU - Hetland, Merete Lund

AU - Glintborg, Bente

N1 - COPECARE

PY - 2023

Y1 - 2023

M3 - Conference abstract for conference

SP - SCR 52(Supplement 131) (pp 21-23)

T2 - Scandinavian Congress of Rheumatology SCR2023

Y2 - 23 August 2023 through 26 August 2023

ER -